Literature DB >> 21633986

High resolution crystal structures of triosephosphate isomerase complexed with its suicide inhibitors: the conformational flexibility of the catalytic glutamate in its closed, liganded active site.

Rajaram Venkatesan1, Markus Alahuhta, Petri M Pihko, Rik K Wierenga.   

Abstract

The key residue of the active site of triosephosphate isomerase (TIM) is the catalytic glutamate, which is proposed to be important (i) as a catalytic base, for initiating the reaction, as well as (ii) for the subsequent proton shuttling steps. The structural properties of this glutamate in the liganded complex have been investigated by studying the high resolution crystal structures of typanosomal TIM, complexed with three suicide inhibitors: (S)-glycidol phosphate ((S)-GOP, at 0.99 Å resolution), (R)-glycidol phosphate, ((R)-GOP, at 1.08 Å resolution), and bromohydroxyacetone phosphate (BHAP, at 1.97 Å resolution). The structures show that in the (S)-GOP active site this catalytic glutamate is in the well characterized, competent conformation. However, an unusual side chain conformation is observed in the (R)-GOP and BHAP complexes. In addition, Glu97, salt bridged to the catalytic lysine in the competent active site, adopts an unusual side chain conformation in these two latter complexes. The higher chemical reactivity of (S)-GOP compared with (R)-GOP, as known from solution studies, can be understood: the structures indicate that in the case of (S)-GOP, Glu167 can attack the terminal carbon of the epoxide in a stereoelectronically favored, nearly linear OCO arrangement, but this is not possible for the (R)-GOP isomer. These structures confirm the previously proposed conformational flexibility of the catalytic glutamate in its closed, liganded state. The importance of this conformational flexibility for the proton shuttling steps in the TIM catalytic cycle, which is apparently achieved by a sliding motion of the side chain carboxylate group above the enediolate plane, is also discussed.
Copyright © 2011 The Protein Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21633986      PMCID: PMC3189524          DOI: 10.1002/pro.667

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  39 in total

1.  The penultimate rotamer library.

Authors:  S C Lovell; J M Word; J S Richardson; D C Richardson
Journal:  Proteins       Date:  2000-08-15

2.  Optimal alignment for enzymatic proton transfer: structure of the Michaelis complex of triosephosphate isomerase at 1.2-A resolution.

Authors:  Gerwald Jogl; Sharon Rozovsky; Ann E McDermott; Liang Tong
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-30       Impact factor: 11.205

3.  Structure validation by Calpha geometry: phi,psi and Cbeta deviation.

Authors:  Simon C Lovell; Ian W Davis; W Bryan Arendall; Paul I W de Bakker; J Michael Word; Michael G Prisant; Jane S Richardson; David C Richardson
Journal:  Proteins       Date:  2003-02-15

4.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

5.  REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use.

Authors:  Alexei A Vagin; Roberto A Steiner; Andrey A Lebedev; Liz Potterton; Stuart McNicholas; Fei Long; Garib N Murshudov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

6.  Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions.

Authors:  E Krissinel; K Henrick
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

7.  Structural and mutagenesis studies of leishmania triosephosphate isomerase: a point mutation can convert a mesophilic enzyme into a superstable enzyme without losing catalytic power.

Authors:  J C Williams; J P Zeelen; G Neubauer; G Vriend; J Backmann; P A Michels; A M Lambeir; R K Wierenga
Journal:  Protein Eng       Date:  1999-03

8.  Structural determinants for ligand binding and catalysis of triosephosphate isomerase.

Authors:  I Kursula; S Partanen; A M Lambeir; D M Antonov; K Augustyns; R K Wierenga
Journal:  Eur J Biochem       Date:  2001-10

9.  Total synthesis of an antitumor antibiotic, Fostriecin (CI-920).

Authors:  Kazuyuki Miyashita; Masahiro Ikejiri; Hitomi Kawasaki; Satoko Maemura; Takeshi Imanishi
Journal:  J Am Chem Soc       Date:  2003-07-09       Impact factor: 15.419

10.  Crystal structure of triosephosphate isomerase complexed with 2-phosphoglycolate at 0.83-A resolution.

Authors:  Inari Kursula; Rik K Wierenga
Journal:  J Biol Chem       Date:  2003-01-09       Impact factor: 5.157

View more
  3 in total

1.  The critical role of the loops of triosephosphate isomerase for its oligomerization, dynamics, and functionality.

Authors:  Ataur R Katebi; Robert L Jernigan
Journal:  Protein Sci       Date:  2013-12-31       Impact factor: 6.725

2.  Evolution of the genetic code by incorporation of amino acids that improved or changed protein function.

Authors:  Brian R Francis
Journal:  J Mol Evol       Date:  2013-06-07       Impact factor: 2.395

Review 3.  The Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases-Part III: In-Silico Molecular Docking Investigations.

Authors:  Ifedayo Victor Ogungbe; William N Setzer
Journal:  Molecules       Date:  2016-10-19       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.